Antitumor activity of orally bioavailable farnesyltransferase inhibitor, ABT-100, is mediated by antiproliferative, proapoptotic, and antiangiogenic effects in xenograft models.
Clin Cancer Res
; 11(8): 3045-54, 2005 Apr 15.
Article
in En
| MEDLINE
| ID: mdl-15837760
Search on Google
Database:
MEDLINE
Main subject:
Apoptosis
/
Alkyl and Aryl Transferases
/
Angiogenesis Inhibitors
/
Xenograft Model Antitumor Assays
/
Imidazoles
/
Antineoplastic Agents
Type of study:
Prognostic_studies
Limits:
Animals
/
Humans
/
Male
Language:
En
Year:
2005
Type:
Article